JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$2.29B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.1B |
| 3 |
Vanguard Total International Bond ETF
BNDX
|
+$1.67B |
| 4 |
AbbVie
ABBV
|
+$1.6B |
| 5 |
ExxonMobil
XOM
|
+$1.5B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$3.99B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.33B |
| 3 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$1.15B |
| 4 |
Tesla
TSLA
|
+$1.05B |
| 5 |
iShares TIPS Bond ETF
TIP
|
+$1.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.04% |
| 2 | Healthcare | 10.96% |
| 3 | Financials | 10.87% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 7.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3726
Sphere Entertainment
SPHR
$6.03B
| $1.68M | ﹤0.01% |
20,208
-34,646
| -63% | -$2.61M |
|
|
MFGP
3727
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
| $1.68M | ﹤0.01% |
316,545
-100,743
| -24% | -$555K |
|
3728
CALL
D.R. Horton
DHI
$41.6B
| $1.68M | ﹤0.01% |
22,500
-140,000
| -86% | -$12.1M |
|
3729
CALL
Royal Caribbean
RCL
$81.6B
| $1.68M | ﹤0.01% |
20,000
-220,700
| -92% | -$17.4M |
|
3730
Invivyd
IVVD
$212M
| $1.67M | ﹤0.01% |
366,392
+353,341
| +2,707% | +$2.16M |
|
|
CLVT.PRA
3731
DELISTED
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
| $1.67M | ﹤0.01% |
24,597
-73,732
| -75% | -$4.99M |
|
|
EXTN
3732
DELISTED
Exterran Corporation
EXTN
| $1.67M | ﹤0.01% |
268,570
+153,708
| +134% | +$819K |
|
|
AOMR
3733
Angel Oak Mortgage REIT
AOMR
$207M
| $1.66M | ﹤0.01% |
101,327
+33,129
| +49% | +$548K |
|
3734
Invesco KBW High Dividend Yield Financial ETF
KBWD
$431M
| $1.66M | ﹤0.01% |
85,168
-821
| -1% | -$16.1K |
|
3735
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.38B
| $1.66M | ﹤0.01% |
15,838
+1,970
| +14% | +$203K |
|
3736
CALL
Silicon Motion
SIMO
$9.12B
| $1.66M | ﹤0.01% |
+24,800
| New | +$1.93M |
|
3737
Yext
YEXT
$594M
| $1.66M | ﹤0.01% |
240,552
-101,486
| -30% | -$775K |
|
3738
Theravance Biopharma
TBPH
$881M
| $1.66M | ﹤0.01% |
173,292
-31,818
| -16% | -$312K |
|
|
IAS
3739
DELISTED
Integral Ad Science
IAS
| $1.65M | ﹤0.01% |
119,294
+88,390
| +286% | +$1.51M |
|
3740
Philips
PHG
$26.7B
| $1.64M | ﹤0.01% |
65,077
-16,305
| -20% | -$445K |
|
3741
Protagonist Therapeutics
PTGX
$10B
| $1.64M | ﹤0.01% |
69,183
-367,270
| -84% | -$10.3M |
|
|
DOG
3742
ProShares Short Dow30
DOG
$87.3M
| $1.64M | ﹤0.01% |
50,100
+49,840
| +19,169% | +$1.64M |
|
3743
Ducommun
DCO
$3.13B
| $1.64M | ﹤0.01% |
31,254
-9,249
| -23% | -$441K |
|
3744
HBT Financial
HBT
$1.35B
| $1.64M | ﹤0.01% |
90,041
-16,881
| -16% | -$321K |
|
|
HUGS
3745
DELISTED
USHG Acquisition Corp.
HUGS
| $1.64M | ﹤0.01% |
161,856
+4,330
| +3% | +$44.3K |
|
3746
PDF Solutions
PDFS
$2.15B
| $1.64M | ﹤0.01% |
58,669
+1,537
| +3% | +$42.9K |
|
3747
First Internet Bancorp
INBK
$254M
| $1.63M | ﹤0.01% |
37,940
-7,341
| -16% | -$355K |
|
3748
State Street SPDR Portfolio Mortgage Backed Bond ETF
SPMB
$7.05B
| $1.63M | ﹤0.01% |
67,892
-28,184
| -29% | -$694K |
|
3749
KRONOS Worldwide
KRO
$975M
| $1.62M | ﹤0.01% |
104,370
-22,388
| -18% | -$333K |
|
3750
Immatics
IMTX
$1.29B
| $1.62M | ﹤0.01% |
202,640
+121,754
| +151% | +$1.11M |
|
Similar funds
JP Morgan Chase's Q1 2022 Portfolio in Review
As of Q1 2022, JP Morgan Chase held 7,378 positions worth $830B, down 4.1% from $866B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q1 2022 filing shows 607 new, 2,657 increased, 2,665 reduced and 679 closed positions. Its largest new stake was iShares AAA-A Rated Corporate Bond ETF: 4,681,132 shares worth $243M. The largest sale was Vanguard Short-Term Bond ETF, an estimated $3.99B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q1 2022 buy was iShares AAA-A Rated Corporate Bond ETF: 4,681,132 shares worth $243M.
- JP Morgan Chase added most to Vanguard Total Bond Market in Q1 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q1 2022 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $3.99B.
- JP Morgan Chase fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $442M.
- JP Morgan Chase's ten largest holdings make up 18% of its $830B portfolio in Q1 2022.
- JP Morgan Chase opened 607 new positions and closed 679 in Q1 2022.
- JP Morgan Chase's portfolio value fell 4.1% quarter-over-quarter to $830B.
Based on JP Morgan Chase's 13F filing for Q1 2022, filed 11 May 2022.